Professional Documents
Culture Documents
Shareholding (%)
Key Result Highlights
Dec-21 Mar-22 June-22
Capacity Expansion
Promoter 54.53 54.53 54.53
Ametha project to get operational in Q4CY22: The capacity expansion project at Ametha,
Madhya Pradesh (2.7 mtpa Clinker and 1 mtpa grinding, 16.3 MW WHRS plant) progressing well FIIs 13.76 12.75 12.11
and is expected to get operational in Q4CY22. The 2.2 mtpa split grinding units in the state of UP MFs / UTI 8.85 9.23 9.38
are progressing well and are expected to get operational in CY23. Tikariya unit (1.60 mtpa) was
Banks / FIs 0.84 0.96 0.6
commissioned in Feb’22 and the project was executed in 9 months. The company’s upcoming
projects are progressing ahead of schedule, which will take its total capacity to 39.3 mntpa from Others 22.02 22.53 23.38
the current 36.1 mntpa.
Financial & Valuations
Kymore & Jamul WHRS plant work on track: The company’s construction of the WHRS plant
at its units in Kymore (10mw) and Jamul (14 MW) is on track and is expected to be commissioned Y/E Dec (Rs Cr) CY21 CY22E CY23E
in CY22. Furthermore, orders have been placed for the next phase of projects at the Chanda and Net Sales 16,152 17.683 19,795
Wadi plants. The total capacity of WHRS will reach 75 MW and will add to savings in power/fuel EBITDA 2,998 1.768 2,699
costs moving ahead. The company’s study to set up other WHRS plants is also in progress.
Net Profit 1,863 9,90 1,638
Press Release Statement
EPS (Rs.) 97 53 88
Rising global fuel costs and related inflationary impacted Q2CY22: Q2CY22 was impacted
PER (x) 21 42 25
by the rising global fuel costs and related inflationary impacts. The company was able to mitigate
part of this impact through its efficiency project ‘Parvat’. The cost reduction journey will be further EV/EBITDA (x) 10 18 12
accelerated with the commissioning of the waste heat recovery projects in Jamul, Kymore, and P/BV (x) 2.7 2.9 2.7
Ametha plants, taking the share of green power to 15%. ROE (%) 14 7 11
Sustainability continues to be one of key focus areas: ACC is committed to making a tangible
difference in the areas of carbon footprint reduction, protection of natural resources, and enabling Change in Estimates (%)
progress and welfare of communities through various initiatives. CY22E CY23E
Outlook & Valuation Revenue -1 -2
Higher costs severely impacted the company’s operational performance in Q2CY22 and H1CY22. EBITDA -35 -24
This resulted in the company reporting its lowest EBITDA margin over the past several years.
While ACC is well-positioned in its key markets with better pricing and volume growth, we foresee Net profit -41 -28
input costs to remain elevated and start subsiding from Q4CY22. Its capacity expansion plans are
progressing well and it is well-poised to capitalize on the growth momentum in the ensuing period ESG disclosure Score**
by tapping its upcoming and expanded capacity in demand accretive Central India region. This will Environmental Disclosure Score 54
also aid the company in gaining market share which it lost to other larger peers over the years.
Social Disclosure Score 56
Furthermore, with its sharp focus on cost optimization measures under project PARVAT, and
increased government focus on infrastructure, housing, PLI scheme, and commercial Governance Disclosure Score 59
development, we expect the company to register Revenue/EBITDA/APAT CAGR of 13%/5%/9% Total ESG Disclosure Score 56
over CY20-CY23E, driven by volume CAGR of 9% and consistent realization improvement of 3% Source: Bloomberg, Scale: 0.1-100
over CY20-23E. The stock is currently trading at 18x & 12x its CY22E and CY23E EV/EBITDA. **Note: This score measures the amount of ESG data a company reports publicly and
does not measure the company's performance on any data point. All scores are
We value ACC at 11x its CY23E EV/EBITDA, factoring in the higher cost and await margins to based on 2020 disclosures
improve to arrive at a TP of Rs 2,010/share, implying a downside of 7% from the CMP and hence
change its rating from BUY to HOLD Relative performance
225
Key Financials (Consolidated)
175
(Rs Cr) CY21 CY22E CY23E
125
Net Sales 16,152 17.683 19,795
75
EBITDA 2,998 1.768 2,699
Shikha Doshi
Research Analyst
email:shikha.doshi@axissecurities.in
1
Key Result Highlights (Cont)
Project PARVAT: Project PARVAT helped the company mitigate part of the rising power/fuel cost during the quarter. Strict
cost control measures enabled the reduction in the fixed cost over the previous year.
Digital Initiatives: ACC is deploying a whole new gamut of digital tools to establish both a superior consumer connect and
technical assistance as well as to enhance the overall consumer experience. The company is implementing various tools
such as Transport Analytics Centre (TAC) to achieve efficiency improvements and has also undertaken various consumer-
centric digitization tools for adding value to customers.
RMX(Ready Mix Concrete): During the quarter, the company’s RMX volume increased by 44% YoY to 0.83 Mn Sq Mt.
Green Concrete “ECOPact” is now a formidable part of the total Ready mix sales. It has further expanded its ECO-friendly
product portfolio by launching a new climate control concrete insulation system ‘AIRIUM’. During the quarter the company
launched DYNAMax under the ready mix product portfolio. The ready mix business is poised for significant growth owing to
low penetration, rapid urbanization, and a focus on infrastructure development. The company has a strong expansion plan
with a wide range of products and a continued focus on expanding green products and solutions.
ESG: ESG remains the company’s key focus area and it is determined to bring more greener products into its portfolio and
undertake several other ESG initiatives. During the quarter, blended cement formed 90% of the company's total cement sales
and the clinker factor stood at 58%. The thermal substitution rate stood at 9%.
Cash Flow: Subdued operating performance and high working capital requirement significantly impacted the H1CY22 cash
flow. During H1CY22, the company reported a negative OCF of Rs.757 cr against a positive OCF of Rs 421 Cr last year.
During the H1CY22, the company spent Rs 1085 cr on ongoing Capex against 343 Cr last year. The cash flow was also
impacted on account of higher dividend payments by the company for CY21. Total cash/cash equivalents stood at Rs 4,516
Cr against Rs 5,689 Cr last year.
2
Story in Charts
Exhibit 1: Volume Trend Exhibit 2: Realization Trend
Q4CY19
Q2CY19
Q3CY19
Q1CY20
Q2CY20
Q3CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q4CY21
Q1CY22
Q2CY22
Source: Company, Axis Securities,
Q3CY20
Q2CY19
Q3CY19
Q4CY19
Q1CY20
Q2CY20
Q3CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q4CY21
Q1CY22
Q2CY22
Q2CY19
Q3CY19
Q4CY19
Q1CY20
Q2CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q4CY21
Q1CY22
Q2CY22
Source: Company, Axis Securities,
Q4CY21
Q2CY19
Q4CY19
Q1CY20
Q2CY20
Q3CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q1CY22
Q2CY22
0.0%
Revenue EBITDA PAT Volume
3
Exhibit 7: Trend in RM Cost Exhibit 8: Staff Cost
Q3CY20
Q2CY19
Q3CY19
Q4CY19
Q1CY20
Q2CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q4CY21
Q1CY22
Q2CY22
Source: Company, Axis Securities, Source: Company, Axis Securities
0 1100
Q4CY21
Q4CY19
Q2CY19
Q3CY19
Q4CY19
Q1CY20
Q2CY20
Q3CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q1CY22
Q2CY22
Q2CY19
Q3CY19
Q1CY20
Q2CY20
Q3CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q4CY21
Q1CY22
Q2CY22
Source: Company, Axis Securities, Source: Company, Axis Securities
600
400
200
0
Q2CY19
Q3CY19
Q4CY19
Q1CY20
Q2CY20
Q3CY20
Q4CY20
Q1CY21
Q2CY21
Q3CY21
Q4CY21
Q1CY22
Q2CY22
4
Q2CY22 Result Comparative (Rs Cr)
5
Financials (Consolidated)
Profit & Loss (Rs Cr)
Y/E March CY21 CY22E CY23E
Net sales 16152 17683 19795
Other operating income 0 0 0
Total income 16152 17683 19795
6
Cash Flow (Rs Cr)
Y/E March CY21 CY22E CY23E
Profit before tax 2506 1320 2183
Depriciation 601 643 712
Interest Expenses 55 53 63
Non operating/ EO item -214 -248 -260
Change in W/C 130 161 -3
Income Tax -286 -330 -546
Operating Cash Flow 2792 1599 2150
Capital Expenditure -1175 -1929 -990
Investments 0 0 0
Others 177 1280 247
Investing Cash Flow -998 -649 -742
Borrowings 0 0 0
Interest Expenses -32 -53 -63
Dividend paid -263 -1128 -564
Others 0 0 0
Financing Cash Flow -295 -1181 -627
Change in Cash 1499 -231 780
Opening Cash 5849 7367 7136
Closing Cash 7348 7136 7916
Source: Company, Axis Securities
7
Ratio Analysis (%)
Y/E March CY21 CY22E CY23E
Operational Ratios
Sales growth 17% 9% 12%
OPM 18.6% 10.0% 13.6%
Op. profit growth 27% -41% 53%
COGS / Net sales 62% 72% 69%
Overheads/Net sales 19% 18% 17%
Depreciation / G. block 5.9% 5.3% 5.4%
Efficiency Ratios
Total Asset turnover (x) 1.57 1.45 1.50
Sales/Gross block (x) 1.57 1.45 1.50
Sales/Net block(x) 2.07 2.20 2.38
Working capital/Sales (x) 0.07 0.05 0.05
Valuation Ratios
PER (X) 23.2 42.1 25.6
P/BV (x) 2.95 2.98 2.77
EV/Ebitda (x) 11.03 18.84 12.06
EV/Sales (x) 2.05 1.88 1.64
EV/Tonne $ (x) 132 123 114
Return Ratios
ROE 13.9 7.0 11.2
ROCE 18.3 9.1 14.5
ROIC 38.9 17.7 30.4
Leverage Ratios
Debt / equity (x) 0.00 0.00 0.00
Net debt/ Equity (x) -0.53 -0.51 -0.53
Interest Coverage ratio (x) 47.68 25.46 35.27
Net debt/ Ebitda (x) -2.51 -4.12 -2.99
8
ACC Ltd Price Chart and Recommendation History
(Rs)
9
About the analyst
Email: uttamkumar.srimal@axissecurities.in
Sector: Cement/Infra
Analyst Bio: Uttam K Srimal is PGDBF from NMIMS with more than 20 years of experience in Equity
Market/Research.
Email: shikha.doshi@axissecurities.in
Sector: Cement/Infra
Analyst Bio: Shikha Doshi is Master of Science in Finance from Illinois Institute of Technology, Chicago,
currently handling Cement/infra sector.
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the
Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is
a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its various subsidiaries
engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are
available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association
of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, Uttam Srimal, (MBA-Finance) and Shikha Doshi (Master of Science in Finance), author/s and the name/s subscribed to this report, hereby certify that
all of the views expressed in this research report accurately reflect my/its views about the subject issuer(s) or securities. I/We (Research Analyst) also certify
that no part of my/its compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/its
relative or ASL does not have any financial interest in the subject company. Also I/we or my/its relative or ASL or its Associates may have beneficial ownership
of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL
are engaged in various financial service businesses, it might have financial interests or beneficial ownership in various companies including the subject
company/companies mentioned in this report. I/we or my/its relative or ASL or its associate does not have any material conflict of interest. I/we have not served
as director / officer, etc. in the subject company in the last 12-month period.Any holding in stock – No
5. 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the
subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates
may have:
Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research
report and / or;
Managed or co-managed public offering of the securities from the subject company of this research report and / or;
Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research
report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection
with this report.
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered
in any way, transmitted to, copied or distributed, in part or in whole, to any other person or the media or reproduced in any form, without prior written consent of ASL. The report is based on the
facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available
media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,
completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer
document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers
may receive this report at the same time. ASL will not treat recipients as customers by their receiving this report.
10
Disclaimer:
DEFINITION OF RATINGS
NOT RATED We have forward looking estimates for the stock but we refrain from assigning valuation and recommendation
UNDER REVIEW We will revisit its recommendation, valuation and estimates on the stock following recent events
NO STANCE We do not have any forward looking estimates, valuation or recommendation for the stock
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the
recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who
must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations
as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks
involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures,
options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or
employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis
of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the
dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advice necessarily a guide to future performance. Investors
are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from
those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the
company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market
maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may
have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a
separate, distinct and independent of each other. The recipient should take this into account before interpreting this document.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this
report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not
based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and
reach different conclusion from the information presented in this report. The Research reports are also available & published on AxisDirect website.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in
the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in
such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use
by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability
or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described
herein may or may not be eligible for sale in all jurisdictions or to certain category of investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of
the views expressed in the report. The company reserves the right to make modifications and alternations to this document as may be required from time to time
without any prior notice. The views expressed are those of the analyst(s) and the company may or may not subscribe to all the views expressed therein.
Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, Dealing office: 1st Floor, I-Rise Building, Q Parc, Loma Park, Thane, Ghansoli, Navi Mumbai-400701, Regd. off.- Axis House,8th Floor,
Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025. Compliance Officer: Anand Shaha, Email: compliance.officer@axisdirect.in, Tel
No: 022-49212706
11